Heterologous boosting immunizations
OwnerRonald S. Chamberlain, Kari R. Irvine +2inventors
InventorsRonald S. Chamberlain, Kari R. Irvine, Steven A. Rosenberg, Nicholas P. Restifo
Life of this patent
Estimating the term…
Abstract
This invention describes methods of vaccination for the effective generation of an antigen-specific immune response. More particularly, this invention describes the use of heterologous vaccination vectors for eliciting an enhanced boosting immunization response. Methods of treatment and prevention of diseases using the vaccination schemes of the invention are also provided.
Claims20
A method for inducing an enhanced immunological response against at least one antigen in a mammal, said method comprising the steps of:
- inoculating the mammal with a first recombinant vector comprising a DNA vector and a gene encoding said antigen;
- and
- inoculating the mammal with a boosting immunization with a second recombinant vector comprising a second DNA vector and the gene encoding said antigen.
The method of immunotherapy for treatment of a cancer patient, said method comprising the steps of:
- immunizing said patient with an effective amount of a first recombinant vector comprising a first viral vector and a gene encoding a tumor-associated antigen;
- and
- boosting said patient with an effective amount of a second recombinant vector comprising a second viral vector and the gene encoding the tumor-associated antigen.
Dependencies are inferred from the claim text.